QuantX Biosciences

QuantX - Transforming the discovery of oral small molecule therapeutics

Princeton, United States · Founded 2022 · $130.0M raised

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$130.0M
Last Round
$45.0M Series AFeb 2026
Rounds
2

About

QuantX Biosciences is a Princeton, New Jersey-based biotechnology company founded in 2022 that uses proprietary computational modeling to accelerate the discovery of oral small molecule therapeutics. The company focuses on immunology and inflammation targets, advancing a pipeline of oral small molecule inhibitors against clinically validated pathways. Co-founded by CTO Yax Sun and CSO Wayne Tang, QuantX raised $85M in an oversubscribed Series B in 2026.

Summary

QuantX Biosciences is a Biotech company based in Princeton, United States, founded in 2022. It has raised $130.0M in total across 2 rounds, most recently a $45.0M Series A round in Feb 2026. Investors include OrbiMed, Lilly Asia Ventures and Sanofi Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BFeb 2026
$85.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

QuantX Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/quantx-biosciences"><img src="https://indexed.vc/api/badge/company/quantx-biosciences" alt="QuantX Biosciences on Indexed.vc" width="260" height="76" /></a>